| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/24/2003 | US20030139468 Antiarrhythmia agent |
| 07/24/2003 | US20030139467 Diuretics containing y-tocotrienol |
| 07/24/2003 | US20030139465 Selected essential amino acid supplementation of dietary proteins to lower urinary urea and peak glucose levels |
| 07/24/2003 | US20030139463 Anticancer agents; antiarthritic agents |
| 07/24/2003 | US20030139462 Antiinflammatory agents; autoimmune disease; antiarthritic agents |
| 07/24/2003 | US20030139461 Antidiabetic formulation and method |
| 07/24/2003 | US20030139460 Antitumor, anticancer agents; antiinflammatory agents; psoriasis; antiarthritic agents; side effect reduction |
| 07/24/2003 | US20030139459 Oral combination of lufenuron and nitenpyram against fleas |
| 07/24/2003 | US20030139458 Stroke; Alzheimer's disease; Parkinson's disease; Huntington's disease |
| 07/24/2003 | US20030139457 Small organic molecule regulators of cell proliferation |
| 07/24/2003 | US20030139456 Deprenyl compounds for treatment of glaucoma |
| 07/24/2003 | US20030139454 Mixture containing an oxyaromatic amide |
| 07/24/2003 | US20030139453 Difluorobutyric acid metalloprotease inhibitors |
| 07/24/2003 | US20030139452 Pyrazole-derived kinase inhibitors and uses thereof |
| 07/24/2003 | US20030139451 Synthesis and anti-tumor activity of nitrogen substituted thalidomide analogs |
| 07/24/2003 | US20030139450 Respiratory syncytial virus |
| 07/24/2003 | US20030139448 Antidiarrhea agents; gastrointestinal disorders |
| 07/24/2003 | US20030139447 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof |
| 07/24/2003 | US20030139446 Reacting with acid mixed with solvent; salt formation |
| 07/24/2003 | US20030139445 Method for treating retroviral infections |
| 07/24/2003 | US20030139443 Anxiolytic agents; veterinary medicine |
| 07/24/2003 | US20030139442 Congestive heart failure |
| 07/24/2003 | US20030139439 Uses of diterpenoid triepoxides as an anti-proliferative agent |
| 07/24/2003 | US20030139438 Blocking metenkephalin; monitoring condition |
| 07/24/2003 | US20030139437 Respiratory system disorders; dextromethorphan in anhydrous solvents |
| 07/24/2003 | US20030139436 Stabilized liquid preparation |
| 07/24/2003 | US20030139435 N-heterocyclic inhibitors of TNF-alpha expression |
| 07/24/2003 | US20030139434 Combinations comprising dipeptidylpeptidase-iv inhibitor |
| 07/24/2003 | US20030139433 Incontinence |
| 07/24/2003 | US20030139431 Guanidines which are agonist/antagonist ligands for neuropeptide FF (NPFF) receptors |
| 07/24/2003 | US20030139430 Use of organic compounds |
| 07/24/2003 | US20030139429 Synergistic mixture of phosphodiesterase and drug such as hypotensive agen, enzyme or antidiabetic agent |
| 07/24/2003 | US20030139428 Purine derivatives for treatment of gastrointestinal disorders, immunological disorders, neurological disorders |
| 07/24/2003 | US20030139425 Piperazine derivatives and their use as anti-inflammatory agents |
| 07/24/2003 | US20030139424 Dietetic therapy |
| 07/24/2003 | US20030139423 Central nervous system disorders; psychological disorders |
| 07/24/2003 | US20030139422 Method for improving respiratory function and inhibiting muscular degeneration |
| 07/24/2003 | US20030139421 Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain |
| 07/24/2003 | US20030139420 Method of increasing milk production |
| 07/24/2003 | US20030139419 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 07/24/2003 | US20030139418 Substituted aryl and heteroaryl compounds as E-type prostaglandin antagonists |
| 07/24/2003 | US20030139417 Cyclopropane CGRP antagonists, medicaments containing these compounds, and method for the production thereof |
| 07/24/2003 | US20030139415 Novel heterocycles 3 |
| 07/24/2003 | US20030139414 Heterocyclic side chain containing, n-substituted metalloprotease inhibitors |
| 07/24/2003 | US20030139413 Novel 1,3-dihydro-2h-indol-2-one derivatives, preparation method and pharmaceutical composition containing them |
| 07/24/2003 | US20030139412 Gastrointestinal disorders |
| 07/24/2003 | US20030139410 Use of modified pyrimidine compounds to promote stem cell migration and proliferation |
| 07/24/2003 | US20030139408 Analgesics; cognition activators |
| 07/24/2003 | US20030139407 Efficient synthesis of 5-heteroatom-containing -pyrazoles |
| 07/24/2003 | US20030139406 Antiinflammatory agents; antidepressants; respiratory system disorders; cognition activators |
| 07/24/2003 | US20030139405 6-Membered heterocyclic compounds useful for selective inhibition of the coagulation cascade |
| 07/24/2003 | US20030139404 N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents |
| 07/24/2003 | US20030139403 Antiinflammatory agents; antidiabetic agents; skin disorders; rheumatic diseases |
| 07/24/2003 | US20030139402 Antiinflammatory agents; Alzheimer's disease; cardiovascular disorders |
| 07/24/2003 | US20030139401 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade |
| 07/24/2003 | US20030139400 Controlling cell differentiation; antiinflammatory agents |
| 07/24/2003 | US20030139399 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
| 07/24/2003 | US20030139398 Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders |
| 07/24/2003 | US20030139396 Constipation; administering devazepide |
| 07/24/2003 | US20030139395 Synergistic mixture; psychological disorders, central nervous system disorders, cardiovascular disorders |
| 07/24/2003 | US20030139394 Dibenzodiazepine derivatives, their preparation and use |
| 07/24/2003 | US20030139393 Substituted homopiperidinyl benzimidazole analogues as fundic relaxants |
| 07/24/2003 | US20030139392 Herbal supplement for increased muscle strength and endurance for athletes |
| 07/24/2003 | US20030139391 Efficacious dosage regimen of galantamine that reduces side effects |
| 07/24/2003 | US20030139389 Gastrointestinal disorders, cardiovascular disorders, central nervous system disorders |
| 07/24/2003 | US20030139387 Using nicotinic acetylcholine receptor |
| 07/24/2003 | US20030139386 Mixture with surfactants; cannabinol receptor; dietetics |
| 07/24/2003 | US20030139385 Method of treating disorder related to high cholesterol concentration |
| 07/24/2003 | US20030139384 Transdermal supplying testosterone |
| 07/24/2003 | US20030139383 Respiratory system disorders |
| 07/24/2003 | US20030139382 Method of treating middle ear infections |
| 07/24/2003 | US20030139381 Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology |
| 07/24/2003 | US20030139380 Orally administering, especially by sustained release, a tetracycline compound or salt in a sub-bactericidal amount that that reduces telangiectasiais but has no antibiotic activity |
| 07/24/2003 | US20030139379 Autoimmune disease, osteoporosis, rheumatic diseases, skin disorders |
| 07/24/2003 | US20030139378 Liquid bisphosphonate formulations for bone disorders |
| 07/24/2003 | US20030139377 Bactericides; enzyme inhibitors |
| 07/24/2003 | US20030139376 Lipoxin A4 analogs |
| 07/24/2003 | US20030139375 Sexual disorders; vision defects; blocking binding to mammal cells |
| 07/24/2003 | US20030139373 Method for cancer therapy |
| 07/24/2003 | US20030139372 Modulation of bone formation |
| 07/24/2003 | US20030139371 Drug for combating sexual dysfunctions |
| 07/24/2003 | US20030139370 Pharmaceutical agents containing acyclovir, fusaric acid and derivatives thereof |
| 07/24/2003 | US20030139368 Antithrombotic and/or anti-inflammatory composition combining purine activity and NSAID activity |
| 07/24/2003 | US20030139365 Expression and export of angiogenesis inhibitors as immunofusins |
| 07/24/2003 | US20030139364 Methods and products for enhancing immune responses using imidazoquinoline compounds |
| 07/24/2003 | US20030139363 Methods and compositions for RNAi mediated inhibition of viral gene expression in mammals |
| 07/24/2003 | US20030139362 Central nervous system disorders; Alzheimer's disease |
| 07/24/2003 | US20030139361 Organ grafting; antiinflammatory agents, autoimmune disease |
| 07/24/2003 | US20030139356 Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds |
| 07/24/2003 | US20030139355 Medicine for orthopaedic surgical application and a treating method using thereof |
| 07/24/2003 | US20030139354 Composition for the treatment and/or the prevention of osteoporosis and/or inflammatory joint diseases |
| 07/24/2003 | US20030139353 Using topoisomerase inhibitor; antiarthritic agents; respiratory system disorders; skin disorders |
| 07/24/2003 | US20030139352 Atp binding cassette drug transporter; antitumor agents; thgerapy for drug resistance |
| 07/24/2003 | US20030139351 NKT cell-activating agents containing alpha-glycosylceramides |
| 07/24/2003 | US20030139350 Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents |
| 07/24/2003 | US20030139346 Polymer stabilized neuropeptides |
| 07/24/2003 | US20030139340 Treatment of sepsis by low dose administration of tissue factor pathway inhibitor (TFPI) |
| 07/24/2003 | US20030139339 Treatment of severe pneumonia by administration of tissue factor pathway inhibitor ( TFPI) |
| 07/24/2003 | US20030139335 Diagnosis of premature infants; collagen forming |
| 07/24/2003 | US20030139332 Use of matrix metalloproteinase inhibitors to mitigate nerve damage |